Teleflex $725 million acquisition of NeoTract

5/9/2017

Private acquisition

Value:

$ 725 million

Status:

Announced

Date:

5/9/2017

Overview:

Teleflex has acquired NeoTract for $725 million.
Neotract develops urological treatments.
Teleflex is a medical technologies provider.
An additional $375 million should be paid by the end of 2020 if certain targets are met.
The transaction is expected to close within the next 30 days.

Katrin Kostadinova - Data analyst

Jurisdiction:

United States

Deal type:

Private acquisition

Practice area:

M&A

Governing law:

United States

Industry sector:

Healthcare

Firms:

Simpson Thacher & Bartlett

Party: Teleflex (Acquirer)

Lawyer: Roxane Reardon

Wilson Sonsini Goodrich & Rosati

Party: Neotract (Target)

Lawyers: Philip Oettinger, Robert Ishii

Related deals